Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DC6LS1
|
|||
Drug Name |
AB-110
|
|||
Drug Type |
Cell therapy
|
|||
Indication | Acute myeloid leukaemia [ICD-11: 2A60; ICD-9: 205] | Phase 1 | [1] | |
Myelodysplastic syndrome [ICD-11: 2A37; ICD-9: 238.7] | Phase 1 | [1] | ||
Company |
Angiocrine Bioscience
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03483324) Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.